asthma/allergy therapeutics (RPR/AMRAD)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameasthma/allergy therapeutics (RPR/AMRAD)
Drug Alias NameN/A
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypersensitivityAsthmaRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCSL Innovation PTY Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCSL Innovation PTY LtdRhone Poulenc Rorer Sa
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthmaRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A